Jeffrey S. Parkin

Array ( [id] => 34020 [patent_doc_number] => 07786288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site' [patent_app_type] => utility [patent_app_number] => 10/971199 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21110 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786288.pdf [firstpage_image] =>[orig_patent_app_number] => 10971199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957948 [patent_doc_number] => 20050214318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Immunogenic composition and method of developing a vaccine based on fusion protein' [patent_app_type] => utility [patent_app_number] => 10/971426 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19367 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214318.pdf [firstpage_image] =>[orig_patent_app_number] => 10971426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 220658 [patent_doc_number] => 07608271 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group' [patent_app_type] => utility [patent_app_number] => 10/950010 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32763 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608271.pdf [firstpage_image] =>[orig_patent_app_number] => 10950010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111132 [patent_doc_number] => 20050208587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Peptides that bind to broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex. uses thereof, compositions therefrom' [patent_app_type] => utility [patent_app_number] => 10/946371 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 90542 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208587.pdf [firstpage_image] =>[orig_patent_app_number] => 10946371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7976721 [patent_doc_number] => 08071107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins' [patent_app_type] => utility [patent_app_number] => 10/572638 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 178 [patent_figures_cnt] => 302 [patent_no_of_words] => 21512 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071107.pdf [firstpage_image] =>[orig_patent_app_number] => 10572638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127250 [patent_doc_number] => 20050058994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Monoclonal antibodies to human immunodeficiency virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/940261 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13768 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058994.pdf [firstpage_image] =>[orig_patent_app_number] => 10940261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208733 [patent_doc_number] => 20050053610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Monoclonal antibodies to human immunodeficiency virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/940392 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13761 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053610.pdf [firstpage_image] =>[orig_patent_app_number] => 10940392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033115 [patent_doc_number] => 20050031624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Monoclonal antibodies to human immunodeficiency virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/940162 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13769 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031624.pdf [firstpage_image] =>[orig_patent_app_number] => 10940162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7152582 [patent_doc_number] => 20050025772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Monoclonal antibodies to human immunodeficiency virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/940237 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13774 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20050025772.pdf [firstpage_image] =>[orig_patent_app_number] => 10940237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7210694 [patent_doc_number] => 20050053925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Monoclonal antibodies to human immunodeficiency virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/940344 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13765 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053925.pdf [firstpage_image] =>[orig_patent_app_number] => 10940344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7210684 [patent_doc_number] => 20050053924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Monoclonal antibodies to human immunodeficiency virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/940262 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13766 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053924.pdf [firstpage_image] =>[orig_patent_app_number] => 10940262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7025365 [patent_doc_number] => 20050019759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Attenuated HIV strains and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/939285 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5308 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019759.pdf [firstpage_image] =>[orig_patent_app_number] => 10939285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675663 [patent_doc_number] => 20080213292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Soluble And Stabilized Trimeric Form Of Gp41 Polypeptides' [patent_app_type] => utility [patent_app_number] => 10/573704 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5325 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213292.pdf [firstpage_image] =>[orig_patent_app_number] => 10573704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 330333 [patent_doc_number] => 07510828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Method of decreasing the infectivity of HIV in a biological sample through the administration of S-antithrombin' [patent_app_type] => utility [patent_app_number] => 10/892676 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 14662 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/510/07510828.pdf [firstpage_image] =>[orig_patent_app_number] => 10892676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7421652 [patent_doc_number] => 20040229220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Construction and characterization of monoclonal antibodies against western equine encephalitis virus' [patent_app_type] => new [patent_app_number] => 10/874370 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5035 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229220.pdf [firstpage_image] =>[orig_patent_app_number] => 10874370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7152602 [patent_doc_number] => 20050025779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'HIV-1 envelope glycoproteins having unusual disulfide structure' [patent_app_type] => utility [patent_app_number] => 10/866527 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23846 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20050025779.pdf [firstpage_image] =>[orig_patent_app_number] => 10866527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 64361 [patent_doc_number] => 07759477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'HIV-1, HIV-2, and SIV pol nucleotide fragments' [patent_app_type] => utility [patent_app_number] => 10/862363 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7454 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 504 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759477.pdf [firstpage_image] =>[orig_patent_app_number] => 10862363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5799342 [patent_doc_number] => 20060034860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Protein-protein interactions in human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 10/853807 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 27038 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034860.pdf [firstpage_image] =>[orig_patent_app_number] => 10853807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276642 [patent_doc_number] => 20040236093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro' [patent_app_type] => new [patent_app_number] => 10/468765 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22218 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20040236093.pdf [firstpage_image] =>[orig_patent_app_number] => 10468765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172615 [patent_doc_number] => 20070073048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Hiv polynucleotides and polypeptides derived from botswana mj4' [patent_app_type] => utility [patent_app_number] => 10/556960 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24591 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20070073048.pdf [firstpage_image] =>[orig_patent_app_number] => 10556960 [rel_patent_id] =>[rel_patent_doc_number] =>)